Inhibitory effects of β-Cyclodextrin and trehalose on nanofibril and AGE formation during glycation of human serum albumin

Protein and Peptide Letters

Volumn 16, Issue 6, 2009, Pages 653-659

  Sharifi, Esmaeel ^a   Sattarahmady, Naghmeh ^a,b   Habibi Rezaei, Mehran ^a   Farhadi, Mohammad ^c   Sheibani, Nader ^d   Ahmad, Faizan ^e   Moosavi Movahedi, Ali Akbar ^a,f  

^a UNIVERSITY OF TEHRAN   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^f Foundation for Advancement of Science and Technology in Iran FAST IR   (Iran)

Author keywords

cyclodextrin; Diabetes; Glucose; Glycation; HSA; Trehalose

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; GLUCOSE; SERUM ALBUMIN; TREHALOSE;

ARTICLE; CIRCULAR DICHROISM; GLYCOSYLATION; HUMAN; METABOLISM; SOLUBILITY; SPECTROFLUOROMETRY;

BETA-CYCLODEXTRINS; CIRCULAR DICHROISM; GLUCOSE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; SERUM ALBUMIN; SOLUBILITY; SPECTROMETRY, FLUORESCENCE; TREHALOSE;

EID: 67650141704     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609788490212     Document Type: Article

References (35)

1. Ahmed, N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract., 2005, 67(1), 3- 21.
2. Voziyan, P.A.; Khalifah, R.G.; Thibaudeau, C.; Yildiz, A.; Jacob, J.; Serianni A.S.; Hudson, B.G. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions. J. Biol. Chem., 2003, 278 , 46616-46624.
3. Schmitt, A.; Schmitt, J.; Münch, G.; Gasic-Milencovic, J. Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. J. Anal. Biochem., 2005, 338, 201-215.
4. Cohen, M.P. Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch. Biochem. Biophys., 2003, 419, 25-30.
5. Shaklai, N.; Garlick, R. L.; Franklin Bunn, H. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem., 1984, 259(6), 3812-3817.
6. He, X.M.; Carter, D.C. Atomic structure and chemistry of human serum albumin. Nature, 1992, 358(6435), 209-215.
7. Bourdon, E.; Loreau, N.; Blache, D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J.,1999, 13, 233-244.
8. Amr Darwish, M.; Othman, A.S. Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus. J. Pharm. Biomed. Anal., 2006, 41, 571-575.
9. Brownlee, M.; Vlassara, H.; Cerami A. Nonenzymic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med.,1984, 101, 527-537.
10. Mierzejewska, D.; Mitrowska, P.; Rudnicka, B.; Kubicka, E.; Kostyra, H. Effect of non-enzymatic glycosylation of pea albumins on their immunoreactive properties. Food Chemistry, 2008, 111(1), 127-131.
11. Zhang, J.; Slevin, M.; Duraisamy, Y.; Gaffney, J.; Smith, C.A.; Ahmed, N. Comparison of protective effects of aspirin, Dpenicillamine and vitamin E against high glucose-mediated toxicity in cultured endothelial cells. Biochim. Biophys. Acta., 2006, 1762, 551-557.
12. Zhao, M.; Yang, N.; Yang, B.; Jiang , Y.; Zhang, G. Structural characterization of water-soluble polysaccharides from Opuntia monacantha cladodes in relation to their anti-glycated activities Food Chem., 2007, 105, 1480-1486.
13. Szejtli, J. Utilization of cyclodextrins in industrial products and processes. J. Mat. Chem., 1997, 7, 575-587.
14. Tokihiro, K.; Arima, H.; Tajiri, S.; Irie, T.; Hirayama, F.; Uekama, K. Improvements of subcutaneous bioavailability of insulin by sulfobutyl ether -cyclodextrin in rats. J. Pharm. Pharmacol., 2000, 52, 911-917.
15. Lee, M. J.; Fennema, O. R. Ability of cyclodextrins to inhibit aggregation of beta-casein. J. Agric. Food Chem., 1991, 39(1), 17-21.
16. Nishant, K. J.; Ipsita, R. Role of trehalose in moisture-induced aggregation of bovine serum albumin. Eur. J .Pharm. Biopharm.,2008, 69(3), 824-834.
17. Baptista, R. P.; Pedersen, S.; Cabrita, G. J. M.; Otzen, D. E.; Cabral, J. M. S.; Melo, E. P. Thermodynamics and mechanism of cutinase stabilization by trehalose. Biopolymers, 2008, 89(6), 538- 547.
18. Xie, G.; Timasheff, S.N. The thermodynamic mechanism of protein stabilization by trehalose. Biophys. Chem., 1997, 64, 25-43.
19. Sattarahmady, N.; Moosavi-Movahedi, A.A.; Ahmad, F.; Hakimelahi, G.H.; Habibi-Rezaei, M.; Saboury, A.A.; Sheibani, N. Formation of the molten globule-like state during prolonged glycation of human serum albumin. Biochim. Biophys. Acta, 2007, 1770(6), 933-942.
20. Barzegar, A.; Moosavi-Movahedi, A. A.; Sattarahmady, N.; Hosseinpour-Faizi, M. A.; Aminbakhsh, M.; Ahmad, F.; Saboury, A. A.; Ganjali, M. R.; Norouzi, P. Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding, Protein. Protein Pept. Lett., 2007, 14, 13-18.
21. Sattarahmady, N.; Moosavi-Movahedi, A. A.; Habibi-Rezaei, M.; Ahmadian, S.; Saboury, A. A.; Heli, H.; Sheibani, N. Detergency effect of nanofibrillar amyloid formation on glycation of human serum albumin. Carbohydrate Res., 2008, 343, 2229-2234.
22. Sattarahmady, N.; Khodagholi, F.; Moosavi-Movahedi, A. A.; Heli, H.; Hakimelahi, G.H. Alginate as an antiglycating agent for human serum albumin. Int. J. Biol. Macromol., 2007, 41, 180-184.
23. Baynes, J.W.; Thorpe, S.R.; Murtiashaw, M.H. Nonenzymatic glucosylation of lysine residues in albumin. Methods Enzymol.,1984, 106, 88-98.
24. Sharma, S.D.; Pandey, B.N.; Mishra, K.P.; Sivakami, S. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro. J. Biochem. Mol. Biol. Biophys.,2002, 6, 233-242.
25. Richards, A.B.; Krakowk, S.; Dexter, L.B.; Schmid, H.; Wolterbeek, A.P.M.; Waalkens-Berendsen, D.H.; Shigoyuki, A.; Kurimoto, M. Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food. Chem. Toxicol., 2002, 40, 871-898.
26. Elbein, A.D. The metabolism of alpha,alpha-trehalose. Adv. Carbohydrate Chem. Biochem., 1974, 30, 227-256.
27. Wyatt, G.R.; Kalf, G.F. The chemistry of insect hymolymph. J. Gen. Physiol., 1957, 40, 833-847.
28. Bouma, B.; Kroon-Batenburg, L.M.J.; Wu, Y.P.; Brunjes, B.; Posthuma, G.; Kranenburg, O.; de Groot , P.G.; Voest, E.E.; Gebbink, M.F.B.G. Glycation induces formation of amyloid cross- structure in albumin. J. Biol. Chem., 2003, 278, 41810-41819.
29. Gao, H.; Wang, Y. N.; Fan, Y. G.; Ma, J. B. Interactions of some modified mono- and bis-b-cyclodextrins with bovine serum albumin. Bioorg. Med. Chem., 2006, 14, 131-137.
30. Jain, N.K.; Roy, I. Role of trehalose in moisture-induced aggregation of bovine serum albumin. Eur. J. Pharm. Biopharm., 2008, 69(3), 824-834.
31. Hopkins, T.R.; Spikes, J.D. Denaturation of proteins in 8 M urea as monitored by tryptophan fluorescence: trypsin, trypsinogen and some derivatives. Biochem. Biophys. Res. Commun., 1968, 30, 540- 545.
32. Vivian, J.T.; Callis, P.R. Mechanisms of tryptophan fluorescence shifts in proteins. Biophys. J., 2001, 80, 2093-2109.
33. Sjohlom, I.; Ljtjngstedt, I. Studies on the tryptophan and drugbinding properties of human serum albumin fragments by affinity chromatography and circular dichroism measurements. J. Biol. Chem., 1973, 248(24), 8434-8441.
34. Watanabe, H.; Kragh-Hansen, U.; Tanase, S.; Nakajou, K.; Mitarai, M.; Iwao, Y.; Maruyama, T.; Otagiri, M. Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem. J., 2001, 357, 269-274.
35. Kaushik, J.K.; Bhat, R. Why is trehalose an exceptional protein stabilizer?: an analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose. J. Biol. Chem.,2003, 278(29), 26458-26465.